Developed and published by the Angiogenesis Foundation, the CME Cancer App is a peer-reviewed professional, CME program designed to give physicians and ...
Developed and published by the Angiogenesis Foundation, the CME Cancer App is a peer-reviewed professional, CME program designed to give physicians and nurses state-of-the-art information and expert perspectives on late-breaking clinical data and new concepts on antiangiogenic cancer treatment and clinical trials. Its unique format incorporates clear and concisely written text and graphics. Striking digital 3-D illustrations highlight the steps of tumor angiogenesis at the organ, cell, and molecular level. Each issue features a roster of internationally renowned guest editors who are authorities on treating specific tumor types, such as colorectal, lung, kidney, liver, breast, brain and other cancers. Targeting Tumor Angiogenesis is a convenient way for busy clinicians to keep up with the antiangiogenic field and learn practical information in a timely fashion. It is adapted for digital and print delivery for effective, rapid learning in clinics, classrooms, office, and during travel, and is distributed nationally to over 11,000 oncology professionals.
Size: 19.27 MB
Price: $ 0.00
Developed by The Angiogenesis Foundation
Day of release: 0000-00-0